Center for Policy Analysis on Trade and Health - CPATH

CPATH EVENT Aug. 26 2009: CAFTA and Access to Meds
Home
TPP and Public Health 2016
Public Health on Fast Track: to House W&M 4-22-15
Support Our Work!
PROTECT HEALTH IN TPP
Campaign: Public Health Voice in Trade Policy
Tobacco Control and the TPP
CPATH on Leaked TPP IP Text
Mexico, Chile on TPP-Tobacco
Tobacco & Trade Consortium 2013
2012: Health Advocates Assert Carve-Out; U.S. Weak TPP/Tobacco Proposal
TPP Forums Jan 2012
Trans Pacific Partnership
Tobacco and Trade Publications
Trade Advisory Committees December 2010
Key Trade Agreements - CPATH Analysis and Commentary
Special 301 Hearings: Change Course!
CPATH at APHA 2009 Trade Advisory Committees
CPATH EVENT Aug. 26 2009: CAFTA and Access to Meds
Trade and Health Forum Program APHA Nov. 2009
About CPATH - Overview
CPATH Article: CAFTA Impact on Meds, Prices
Press Release: CPATH on CAFTA in Health Affairs
CAFTA aumenta los precios de medicamentos
Congressional Hearing on Trade Advisory Committees
Towards Change: Korea; Peru; Public Health Objectives
Trade & Health at APHA 2008
Global Trade Events at APHA November 2007
Thailand's Compulsory Licenses for Medicines
Globalization and Health Resource Center - Overview
Key Issues
CPATH Publications
Related Resources
CPATH Presentations
CPATH at US Social Forum 2007
Monterey Forum 2005
FTAA Forum
Public Health Summary Statements on Free Trade Agreements
Resolutions
Sign-On Statements
More About CPATH

Access to Affordable Medicines?

The Case of CAFTA in Guatemala

 

 

You are invited to the release of the new study in Health Affairs which for the first time documents the effects of the Central-America-Dominican Republic-U.S. Free Trade Agreement (CAFTA-DR) on access to medicines.  A light lunch will be served.

 

Wednesday, August 26, Noon- 2:00 pm

University of California DC Washington Center,

 

1608 Rhode Island Ave. NW

 

Does CAFTA affect access to affordable life-saving medicines in Guatemala?

 

  How are CAFTA trade rules affecting access to low-cost generics to treat HIV/AIDS and other major diseases?

 

  Can trade rules affect drug  affordability in the U.S.?

 

 What does this mean for the future of U.S. trade policy?

 

                                                       

        Join:

                                                       

Ellen R. Shaffer, PhD MPH

and

 

Joe Brenner, MA

 

Co-Directors, Center for Policy Analysis on Trade and Health (CPATH)

 

Please RSVP, acceptances only, to Joseph R. McGhee at the IGCC Washington office: Phone (202) 974-6295; Fax (202) 974-6299; email:  joseph.mcghee@ucdc.edu .  For more on IGCC, see http://www-igcc.ucsd.edu. 

 

Click here to download flyer for Aug. 26 event

Bringing a Public Health Voice to Global Trade and Sustainable Development
CPATH
Ellen R. Shaffer and Joe Brenner, Co-Directors
P.O. Box 29586, San Francisco, CA 94129
phone 415-922-6204